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niquet induced cardiovascular responses under general anesthesia.
Method: In a randomized, double blind, placebo-controlled study; thirty adult male patients with
ASA physical status I or II, aged 18–50 years underwent anterior cruciate ligament reconstruction
with a tourniquet under general anesthesia, were divided to receive either oral amantadine 200 mg
capsule in the evening before surgery and 200 mg capsule 60 min before surgery (group A) or pla-
cebo capsules (group P). Heart rate, systolic and diastolic blood pressures were recorded (before
induction of anesthesia, every 15 min after tourniquet inﬂation, before tourniquet deﬂation, and
10 min after tourniquet deﬂation). Incidence of tourniquet-induced hypertension, and postoperative
tramadol consumption were also recorded.
Results: Systolic and diastolic pressures signiﬁcantly increased in both groups compared to base-
line values (P< 0.05) at 15, 30, 45, 60, 75 min after tourniquet inﬂation, and before tourniquet
deﬂation with signiﬁcantly lesser increase with amantadine compared to placebo at 45, 60, and
75 min after tourniquet inﬂation (P< 0.05). Heart rate signiﬁcantly increased at 45, 60, and
75 min after tourniquet inﬂation in both groups compared to baseline values (P< 0.05) with sig-
niﬁcantly lesser increase with amantadine compared to placebo (P< 0.05). Development of tour-
niquet induced hypertension was less with amantadine (5 out of 15) than with placebo (8 out of
15).The total tramadol consumed during the ﬁrst 24 h postoperative was signiﬁcantly less with
amantadine compared to placebo (P< 0.05).
30 A.A. Elmawgood et al.Conclusion: Preoperative oral amantadine reduced tourniquet induced hypertension and postoper-
ative analgesic requirements in anterior cruciate ligament reconstruction surgery under general
anesthesia.
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Pneumatic tourniquets are widely used during the upper or
lower limbs orthopedic surgery to provide bloodless surgical
ﬁeld. However, the associated pain and increase in the arterial
blood pressure are frequently observed 30–60 min after tourni-
quet inﬂation in spite of adequate level of anesthesia and they
are often resistant to profound depth of anesthesia and analge-
sic drugs [1]. Tourniquet induced hypertension occurs more
frequent under general anesthesia than spinal anesthesia and
more with lower limb tourniquet than with upper limb tourni-
quet and can be serious in patients with cardiovascular dis-
eases, neurological diseases, or glaucoma. The exact
mechanism of its development is still unclear [2].
Several methods were used to attenuate tourniquet pain
and hypertension intra-operatively such as the use of regional
anesthesia, intravenous (IV) opioids (remifentanil) [3], a2 ago-
nists (clonidine and dexmedetomidine) [4,5].
There are several attempts to use N-methyl-D-aspartate
(NMDA) receptor antagonists (Ketamine, magnesium, and
dextromethorphan) to attenuate tourniquet-induced pain and
hypertension and have reported to be effective [1,2,4,6,7].
Amantadine (1-aminoadamantane), a non-competitive
NMDA antagonist, was used for long period as an antiviral
against inﬂuenza and for the treatment of Parkinsonism. It
has been used in some studies to reduce postoperative analge-
sic requirements [8,9] but to our knowledge there were no stud-
ies used this drug to reduce tourniquet induced hypertension.
Therefore, the purpose of this study was to test the effect of
preoperative oral amantadine, as an NMDA antagonist, on
tourniquet-induced hypertension under general anesthesia as
a primary outcome and postoperative analgesic requirements
and side effects as a secondary outcome.2. Method
After approval of the local ethical committee, informed written
consents were obtained from 30 adult male patients, American
Society of Anesthesiologists (ASA) physical status I or II, age
ranging between 18 to 50 years old, scheduled for elective ante-
rior cruciate ligament reconstruction with a tourniquet under
general anesthesia.
This randomized, double blind, placebo controlled study
was carried out in Dar Alshifa hospital (State of Kuwait) dur-
ing the period from April 2013 to September 2013.
Patients were excluded from the study if they had sickle cell
disease, peripheral vascular disease, history of DVT, poorly
controlled hypertension, history of allergy to the studied drug
or recent ingestion of cough suppressant (dextromethorphan),
morbid obesity (BMI > 35).
Patients were randomly assigned into two equally divided
groups (15 patients each) by using the closed envelop tech-
nique. The studied drugs were given by an anesthesia nurseunaware of the study medication as per the sealed envelope
instruction (to maintain the blind nature of the study) as
follows:
Amantadine group (group A): the patients received oral
amantadine 200 mg capsule in the evening before surgery
and 200 mg capsule 60 min before surgery (Symmetrel, Nov-
artis pharma AG., Basel, Switzerland) using the dose used in
the study of Snijdelaar et al. [8]
Placebo group (group P) (control group): the patients
received placebo capsules.
During the preoperative anesthesia visit, the patients were
informed about the study and how to use the patient con-
trolled analgesia (PCA) machine postoperatively. The patients
were premedicated with i.v. metoclopramide 10 mg and oral
midazolam 5 mg 60 min before surgery.
When the patients reached the operation room, the moni-
tors were attached including ECG, pulse oximetry, non-inva-
sive arterial blood pressure cuff, skin temperature probe and
bispectral index (BIS) (the BIS electrodes were placed on the
forehead and were connected to the BIS monitoring system)
(Aspect Medical Systems, Leiden, The Netherlands) with infu-
sion of Ringer’s lactate solution according to fasting volumes,
and maintenance volumes.
General anesthesia was induced with fentanyl 2 lg/kg, pro-
pofol 2 mg/kg, lidocaine 1 mg/kg and cisatracurium 0.15 mg/
kg intravenously. The patients were intubated with oral cuffed
tube lubricated with lidocaine gel 2% 2 min after cisatracuri-
um administration and mechanically ventilated to maintain
end tidal CO2 between 35 to 40 mmHg.
Anesthesia was maintained with sevoﬂurane 1.5% in 50%
air/O2 mixture with adjustment of the sevoﬂurane concentra-
tion to maintain BIS value between 40 to 60. Analgesia was
maintained by additional dose of fentanyl 50–100 lg if there
were signs of inadequate analgesia (>20% increase in the
heart rate and mean arterial blood pressure from the baseline).
Esmolol 25 mg increments were given when systolic blood
pressure (SBP), diastolic blood pressure (DBP) or heart rate
(HR) increased >30% from the baseline reading. Muscle
relaxation was maintained with cisatracurium boluses
0.03 mg/kg guided by peripheral nerve stimulator.
The pneumatic tourniquet (PTS ii portable tourniquet sys-
tem, Delﬁ Medical Innovations Inc, Vancouver, Canada)
20 cm width was applied over cotton layer on the thigh of
the operated limb which was elevated at 45 for 5 min with
exsanguination using crepe bandage and inﬂation of the tour-
niquet pressure at 300 mmHg.
At the end of the surgery, the tourniquet was deﬂated with
discontinuation of all anesthetics and the patients were extu-
bated after reversal of neuromuscular blockade with intrave-
nous 0.05 mg/kg neostigmine and 0.02 mg/kg atropine, and
the patients were shifted to postanesthesia care unit (PACU)
for monitoring and observation. The postoperative pain was
treated according to our hospital protocol with tramadol
25 mg intravenous followed by intravenous PCA tramadol
Table 1 Patients characteristics, tourniquet time and opera-
tion time.
Variables Group P (n= 15) Group A (n= 15)
Age (year) 32.2 (5.6) 33.9 (6.8)
Weight (kg) 80.9 (4.1) 85.5 (3.1)
Height (cm) 174.3 (3.5) 175.5 (4.5)
ASA (I/II) 11/4 9/6
Tourniquet time (min) 87.8 (2.2) 88.3 (1.8)
Operation time (min) 118.7 (2.2) 119.1 (2.3)
Group P: placebo group, Group A: amantadine group.
Data presented as mean (SD) or number. No signiﬁcant difference
between groups.
Effect of amantadine on tournique induced cardiovascular response 31(bolus dose 10 mg, lockout time 15 min, and maximum limit
60 mg/4 h with no back ground infusion) for 24 h with addi-
tional intravenous tramadol 25 mg if the patients complained
of pain during PCA (IVACPCAM, Cardinal Health,
Switzerland).
The following parameters were recorded by an anesthesia
nurse unaware of study medication; HR, SBP, and DBP were
recorded at the following time: before induction of anesthesia
(baseline), every 15 min after tourniquet inﬂation, before tour-
niquet deﬂation, and 10 min after tourniquet deﬂation, inci-
dence of tourniquet-induced hypertension (deﬁned as an
increase of systolic or diastolic blood pressure >30% from
baseline), time to ﬁrst postoperative analgesic requirement,
postoperative tramadol consumption during the ﬁrst 24 h after
surgery, postoperative side effects such as nausea and vomiting
(treated with ondansetron 4 mg i.v.) or sedation [graded on a
ﬁve-point scale: (1) fully awake and oriented; (2) drowsy; (3)
eyes closed, arousable to command; (4) eyes closed, arousable
to physical stimulation; and (5) eyes closed, unrousable to
physical stimulation] [10].
3. Statistical analysis
After a pilot study with ten patients, the mean maximum SAP
(SD) was 123 (8.7) and 147 (8.9) in the amantadine group and
the placebo group, respectively. Therefore, using the program
of biostatistics version 3.01, the sample size was calculated as
minimum ﬁve per group was needed to show a difference of
maximum SAP 24 mmHg (SD 9 mmHg) between groups with
the power set at 90% and the a-error level ﬁxed at 0.05. How-
ever, we recruited 15 patients for each group.
Data values were presented as means (SD), or number (%).
Numerical data were analyzed by using Student’s unpaired t-
test. Nonparametric data were analyzed by using the Mann
Whitney U-test. A value of P< 0.05 was considered signiﬁ-
cant. All statistical calculations were done using computer pro-
grams Microsoft Excel version 7 (Microsoft Corporation, NY,
USA).
4. Result
Both groups of patients were similar regarding patients’ char-
acteristics, tourniquet time and operation time (Table 1).
There was no signiﬁcant difference between the two groups
in systolic pressure, diastolic pressure, and heart rate values
before induction of anesthesia (BI) (baseline) (Table 2).
Systolic and diastolic blood pressures signiﬁcantly
increased in both groups compared to baseline values
(P< 0.05) at Ti15, Ti30, Ti45, Ti60, Ti 75, and BTD with sig-
niﬁcantly lesser increase in amantadine group compared to
placebo group at Ti45, Ti60, and Ti 75 (P< 0.05) with return
back to normal values after tourniquet deﬂation (Table 2).
Heart rate signiﬁcantly increased at Ti45, Ti60, and Ti 75 in
both groups compared to baseline values (P< 0.05) with sig-
niﬁcantly lesser increase in amantadine group compared to
placebo group (P< 0.05) with return back to normal values
after tourniquet deﬂation (Table 2).
The number of patients showed tourniquet hypertension
and given esmolol to control the hypertension was more in pla-
cebo group 8 out of 15 (53.3%) than amantadine group 5 out
of 15 (33.3%) (Fig. 1).Time to ﬁrst request of analgesia was signiﬁcantly longer in
amantadine group compared to placebo group (P< 0.05).
Also, total postoperative tramadol consumption during the
ﬁrst 24 h was signiﬁcantly less in amantadine group compared
to placebo group (P< 0.05) (Table 3).
The incidence of postoperative nausea and vomiting was
comparable in both groups without development of postoper-
ative sedation in both groups (Table 4).5. Discussion
This study demonstrated that preoperative oral amantadine
attenuated the increase in blood pressure and heart rate asso-
ciated with tourniquet inﬂation compared with placebo with
reduction of the incidence of the tourniquet-induced hyperten-
sion from 53.3% in placebo group to 33.3% in amantadine
group with decrease in the number of patients given esmolol
to control the hypertension or tachycardia from 8 out of 15
in placebo group to 5 out of 15 in amantadine group.
The exact mechanism of the cardiovascular changes associ-
ated with tourniquet inﬂation is unknown [2]. However, few
theories tried to explain the tourniquet-induced hypertension.
One theory suggested that the development of the tourniquet
pain causes activation of the sympathetic nervous system. This
theory is supported by the ﬁnding that the onset of the tourni-
quet-induced hypertension is analogous to the onset of tourni-
quet pain and both usually occurred 30–60 min after cuff
inﬂation [11], Tetzlaff et al., concluded that there is a correla-
tion between tourniquet induced hypertension and sympa-
thetic nervous system activation [12], Heropoulos et al.,
found increase in plasma catecholamines in association with
tourniquet hypertension [13], and preoperative clonidine sup-
presses the cardiovascular and hyperadrenergic response to
tourniquet inﬂation [4,14].
Another theory suggested that tourniquet inﬂation causes
tissue ischemia with discharge of impulses in both large
myelinated A ﬁbers and unmyelinated C ﬁbers, the A ﬁbers
rapidly undergo conduction block with disinhibition of pain
perception conducted by C ﬁbers. Continuous ﬁring of C
ﬁber nociceptors causes activation of NMDA receptors in
the dorsal horn of the spinal cord leading to central
sensitization [2].
We suggested that oral amantadine, as an NMDA
antagonist, attenuated the tourniquet induced cardiovascular
changes through attenuation of the central sensitization and
Table 2 Hemodynamic changes.
Group SAP DAP HR
BI (baseline) P 119.7 (1.7) 71.2 (2.6) 76.4 (3.2)
A 120.7 (1.3) 73.3 (2.9) 75.2 (1.7)
Ti 15 P 125.1 (1.6)* 75.1 (2.9)* 76.9 (2.6)
A 123.9 (3.2)* 75.9 (2.7)* 75.1 (1.8)
Ti 30 P 135.5 (12.1)* 81.7 (6.4)* 77.3 (2.5)
A 131.4 (6.9)* 79.1 (5.5)* 75.2 (1.7)
Ti 45 P 142.1 (11.6)* 88.8 (8.9)* 85.5 (4.5)*
A 132.8 (10.9)*,a 81.3 (6.6)*,a 80.2 (5.1)*,a
Ti 60 P 144.1 (14.8)* 90.6 (8.8)* 90.3 (5.5)*
A 134.7 (14.6)*,a 83.7 (11.2)*,a 85.3 (7.9)*,a
Ti 75 P 133.1 (2.7)* 79.4 (2.8)* 86.4 (1.8)*
A 128.1 (3.1)*,a 76.6 (1.8)*,a 82.9 (4.8)*,a
BTD P 129.3 (1.4)* 74.7 (2.3)* 79.9 (3.3)
A 126.5 (1.9)* 75.2 (1.9)* 78.7 (4.2)
ATD P 120.5 (1.4) 72.9 (1.2) 75.1 (1.5)
A 120.2 (1.1) 72.8 (2.3) 73.5 (1.5)
Group P: placebo group, Group A: amantadine group. Data presented as mean (SD).
SAP: systolic arterial pressure, DAP: diastolic arterial pressure, HR: heart rate, BI: before induction of anesthesia, Ti15: 15 min after tourniquet
inﬂation, Ti30: 30 min after tourniquet inﬂation, Ti45: 45 min after tourniquet inﬂation, Ti60: 60 min after tourniquet inﬂation, Ti75: 75 min
after tourniquet inﬂation, BTD: before tourniquet deﬂation, ATD: after tourniquet deﬂation.
* Signiﬁcant difference (p< 0.05) Compared to baseline.
a Signiﬁcant difference (p< 0.05) compared to placebo.
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Figure 1 incidence of tourniquet induced hypertension Group P:
placebo group, Group A: amantadine group. No signiﬁcant
difference between groups.
Table 4 Incidence of side effects.
Variables Group P (n= 15) Group A (n= 15)
Nausea & vomiting 3 (20) 2 (13)
Sedation 0 (0) 0 (0)
Group P: placebo group, Group A: amantadine group, data pre-
sented as number (%).
No signiﬁcant difference between groups.
32 A.A. Elmawgood et al.modulation of the transmission of peripheral noxious stimuli
from periphery toward the higher centers in the brain.
This theory was supported by the previous studies of
Yamashita and colleagues who showed that preoperative oral
dextromethorphan reduced the increase in arterial blood pres-
sure and heart rate during tourniquet inﬂation [1], Park and
colleagues concluded that pre-operative intravenous ketamine
(0.1 mg/kg) signiﬁcantly prevents systemic arterial hyperten-
sion during tourniquet inﬂation under general anesthesia [2],
and Satsumae et al., reported that magnesium sulfate reduced
the tourniquet pain in healthy volunteers [6].Table 3 Time to ﬁrst postoperative analgesic requirement and tram
Variables
Time to ﬁrst postoperative analgesic requirement (min)
Tramadol consumption during the ﬁrst 24 h after surgery (mg)
Group P: placebo group, Group A: amantadine group, data presented a
* Signiﬁcant difference (p< 0.05) compared to Group P.In this study preoperative amantadine administration sig-
niﬁcantly reduced the postoperative tramadol consumption
with increase in the time to request of the ﬁrst dose of postop-
erative analgesia, this could be explained by potentiation of the
analgesic action of tramadol by amantadine through NMDA
receptor blockade, this ﬁnding is in agreement with the reports
of Snijdelaar et al. [8] and Bujak-Gi _zycka et al. [9] who
observed reduction of postoperative morphine consumption
with amantadine.
Adequate depth of anesthesia was maintained during the
study by maintaining BIS value between 40 to 60 by adjust-
ment of sevoﬂurane concentration, also adequate analgesia
and muscle relaxation were maintained by additional doses
of fentanyl and cisatracurium respectively to exclude their
inadequacy as causes of intraoperative hypertension and
tachycardia.adol consumption during the ﬁrst 24 h after surgery.
Group P (n= 15) Group A (n= 15)
8.9 (1.4) 18.8 (1.5)*
389.3 (11.2) 311.7 (6.9)*
s mean (SD).
Effect of amantadine on tournique induced cardiovascular response 33Amantadine did not increase the incidence of postoperative
nausea and vomiting because we used only two doses of aman-
tadine as the same used in the study of Snijdelaar and
colleagues [8] who found the same results, in addition admin-
istration of the tramadol in relative low doses in PCA did not
increase the incidence of nausea and vomiting [15], also pro-
phylactic administration of antiemetic (metoclopramide) with
tramadol lower the incidence of associated nausea and
vomiting [16].
We concluded that preoperative use of oral amantadine
reduced the tourniquet induced hypertension with reduction
of postoperative analgesic requirements in anterior cruciate
ligament reconstruction surgery under general anesthesia. Fur-
ther studies are required on more number of patients to con-
ﬁrm the effectiveness of oral amantadine on the tourniquet
induced hypertension.
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